Literature DB >> 12381097

Successful immunoglobulin treatment for fulminant myocarditis and serial analysis of serum thioredoxin: a case report.

Keisuke Shioji1, Yasushi Matsuura, Tomoyuki Iwase, Shouji Kitaguchi, Hajime Nakamura, Junji Yodoi, Tetsuo Hashimoto, Chuichi Kawai, Chiharu Kishimoto.   

Abstract

A 31-year-old woman suspected to have acute myocarditis was admitted to hospital and was managed with intra-aortic balloon pumping and a percutaneous cardiopulmonary support system because of sustained ventricular tachycardia. After immunoglobulin treatment, cardiac function and systematic inflammation were improved. The left ventricular endomyocardial biopsy revealed massive necrosis and degeneration of myocardial cells, and extensive infiltration of inflammatory cells. The clinicopathology of this patient was thought to be fulminant myocarditis. Serial serum thioredoxin (TRX) analysis showed that the serum level was high during the acute phase, and decreased during the chronic phase. Immunohistochemistry for TRX in the biopsy samples showed that inflammatory cells and cardiomyocytes were positively stained.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12381097     DOI: 10.1253/circj.66.977

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  12 in total

Review 1.  [Treatment of progressive heart failure: pharmacotherapy, resynchronization (CRT), surgery].

Authors:  Bernhard Maisch; Sabine Pankuweit
Journal:  Herz       Date:  2010-03       Impact factor: 1.443

2.  Regulation of oxidative stress in patients with Kawasaki disease.

Authors:  Kaori Sekine; Hiroyuki Mochizuki; Yoshinari Inoue; Tohru Kobayashi; Eisuke Suganuma; Shinichi Matsuda; Hirokazu Arakawa
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

Review 3.  Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy.

Authors:  B Maisch; S Pankuweit
Journal:  Herz       Date:  2012-09       Impact factor: 1.443

Review 4.  Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives.

Authors:  Bernhard Maisch; Sabine Pankuweit
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

5.  Overexpression of thioredoxin-1 reduces oxidative stress in the placenta of transgenic mice and promotes fetal growth via glucose metabolism.

Authors:  Takashi Umekawa; Takashi Sugiyama; Tomohisa Kihira; Nao Murabayashi; Lingyun Zhang; Kenji Nagao; Yuki Kamimoto; Ning Ma; Junji Yodoi; Norimasa Sagawa
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

6.  Successful high-dose intravenous immunoglobulin therapy for a patient with fulminant myocarditis.

Authors:  Shigeru Kato; Shin-ichiro Morimoto; Shinya Hiramitsu; Akihisa Uemura; Masatsugu Ohtsuki; Yasuchika Kato; Kenji Miyagishima; Nami Mori; Hitoshi Hishida
Journal:  Heart Vessels       Date:  2007-01-26       Impact factor: 2.037

Review 7.  Management of fulminant myocarditis: a diagnosis in search of its etiology but with therapeutic options.

Authors:  Bernhard Maisch; Volker Ruppert; Sabine Pankuweit
Journal:  Curr Heart Fail Rep       Date:  2014-06

Review 8.  A systematic review of intravenous gamma globulin for therapy of acute myocarditis.

Authors:  Joan L Robinson; Lisa Hartling; Ellen Crumley; Ben Vandermeer; Terry P Klassen
Journal:  BMC Cardiovasc Disord       Date:  2005-06-02       Impact factor: 2.298

9.  Diagnosis and treatment of myocarditis: the role of endomyocardial biopsy.

Authors:  Konstantinos Karatolios; Sabine Pankuweit; Bernhard Maisch
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-12

10.  Intravenous immunoglobulin in the therapy of adult acute fulminant myocarditis: A retrospective study.

Authors:  Dan-Qing Yu; Ying Wang; Gui-Zhou Ma; Rong-He Xu; Zhi-Xiong Cai; Chu-Min Ni; Ping Chen; Zhi-Dan Zhu
Journal:  Exp Ther Med       Date:  2013-10-29       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.